Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018

The global genomics market was valued at $11.11 billion in 2013, and is expected to grow at a CAGR of over 12.0% from 2013 to 2018. The penetration of new markets through the expansion of genomics applications, and advancements in existing technologies plays an important role in attracting new market participants to invest in this market. Next Generation Sequencing (NGS) in personalized medicine and molecular diagnostics is considered as a high growth area for the global genomics market. This new technology provides an affordable and accurate screening solution for genetic mutations. Moreover, the increasing volume of novel genetic tests for personalized medicine and biomarker discovery ensures the continued growth of this market.
Tier I and Tier II companies were found to be dominant in the instrument and consumables segments of the genomics market. The genomics market is becoming increasingly consolidated. Among all market players, Roche Diagnostics, Life Technologies, and QIAGEN together accounted for over 47.0% of the revenues earned by the global genomics market in 2013. This concentration of market shares with Tier I market players is expected to challenge market growth. However, technological advancements, and increasing investments are expected to continue to drive the growth of the global genomics market.
This report provides comprehensive analysis of market dynamics – drivers, restraints, key market metrics, current market trends, competitive structure, and market revenues and forecasts from 2013 to 2018. It also includes an analysis of mergers and acquisitions in the global genomics market over the last ten years, in addition to technology roadmaps for key technology areas in this market. As a part of the premium insights section, current growth strategies adopted by market participants in the global genomics market have been detailed and analyzed.

Table Of Contents


1 Introduction (Page No. - 10)
1.1 Research Methodology
1.2 Market Segmentation
1.3 Market Scope
1.4 Market Definitions
1.5 Classification of Tiers

2 Executive Overview (Page No. - 26)
2.1 Key Findings
2.2 Executive Summary

3 Total Global Genomics Market (Page No. - 37)
3.1 Market Overview
3.2 Market Metrics
3.3 Market Dynamics: Drivers and Restraints
3.4 Revenue and Forecasts
3.5 Forecast Assumptions
3.6 Competitive Structure
3.7 Market Share Analysis

4 Global Genomics Market, By Product Segment (Page No. - 53)
4.1 Product Segmentation
4.1.1 Percent Revenue Split By Product Segment
4.2 Instruments - Market Overview
4.2.1 Revenue Split By Sub-Segment
4.2.2 Market Metrics
4.2.3 Revenue and Forecasts
4.2.4 Revenue and Forecasts Discussion
4.2.5 Competitive Structure
4.2.6 Market Share Analysis
4.3 Consumables - Market Overview
4.3.1 Revenue Split By Sub-Segment
4.3.2 Market Metrics
4.3.3 Revenue and Forecasts
4.3.4 Revenue and Forecasts Discussion
4.3.5 Competitive Structure
4.3.6 Market Share Analysis
4.4 Services - Market Overview
4.4.1 Revenue Split By Sub-Segment
4.4.2 Market Metrics
4.4.3 Revenue and Forecasts
4.4.4 Revenue and Forecasts Discussion
4.4.5 Competitive Structure
4.4.6 Market Share Analysis

5 Global Genomics Market, By Technology (Page No. - 84)
5.1 Technology Segmentation
5.1.1 Percent Revenue Split By Technology Segment
5.1.2 Revenue By Technology Segment
5.1.3 Global Genomics Market – Discussion of Revenue Split, By Technology
5.2 Nucleic Acid Extraction & Purification – Introduction
5.2.1 Revenue Split By Sub-Segment
5.2.2 Technology Roadmap
5.2.3 Market Discussion
5.3 DNA Amplification – Introduction
5.3.1 Revenue Split By Sub-Segment
5.3.2 Technology Roadmap
5.3.3 Market Discussion
5.4 DNA Sequencing – Introduction
5.4.1 Revenue Split By Sub-Segment
5.4.2 Technology Roadmap
5.4.3 Market Discussion
5.5 DNA Microarray – Introduction
5.5.1 Revenue Split By Sub-Segment
5.5.2 Market Discussion
5.6 Analysis of Market Participation in Current and Emerging Technologies

6 Global Genomics Market, By Application (Page No. - 110)
6.1 Application Segmentation
6.1.1 Percent Revenue Split By Application Segment
6.1.2 Revenue By Application Segment
6.1.3 Market Discussion
6.1.4 Discussion of Revenue By Application Segment

7 Global Genomics Market, By Geography (Page No. - 119)
7.1 Geographic Segmentation
7.1.1 Global Genomics Market – Geographic Scope
7.1.2 Percent Revenue Split By Geography
7.1.3 Forecasted Percent Revenue Split By Geography
7.1.4 Revenue & Forecasts By Geography
7.1.5 Revenue & Forecasts Discussion
7.2 North America
7.2.1 Market Overview
7.2.2 Market Metrics
7.2.3 Revenue and Forecasts
7.3 Europe
7.3.1 Market Overview
7.3.2 Market Metrics
7.3.3 Revenue and Forecasts
7.4 Asia-Pacific
7.4.1 Market Overview
7.4.2 Market Metrics
7.4.3 Revenue and Forecasts
7.5 Rest of World
7.5.1 Market Overview
7.5.2 Market Metrics
7.5.3 Revenue and Forecasts

8 Mergers and Acquisitions (Page No. - 143)
8.1 Timeline Analysis of Mergers & Acquisitions
8.2 Analysis of Restructuring Activities
8.3 Analysis of Restructuring Activities, By Motive
8.4 M&A Analysis – Discussion
8.5 List of Restructuring Activities

9 Competitive Strategies (Page No. - 158)
9.1 Acquisition Strategies
9.2 Investment Strategies
9.3 Market Leadership Strategies

10 Company Profiles (Page No. - 168)
10.1 Affymetrix, Inc.
10.2 Agilent Technologies, Inc.
10.3 BGI
10.4 Bio-Rad Laboratories, Inc.
10.5 Cepheid
10.6 Ge Healthcare
10.7 Illumina, Inc.
10.8 Life Technologies, Corp.
10.9 Qiagen
10.10 Roche Diagnostics

11 Appendix (Page No. - 234)
11.1 Database of Key Industry Players By Tier & Product Profile
11.2 List of Public Health Genomics Research Organizations By Country
11.3 List of Tables
11.4 List of Figures